These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11285997)

  • 1. Emerging anabolic treatments for osteoporosis.
    Rosen CJ; Rackoff PJ
    Rheum Dis Clin North Am; 2001 Feb; 27(1):215-33, viii. PubMed ID: 11285997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical review 123: Anabolic therapy for osteoporosis.
    Rosen CJ; Bilezikian JP
    J Clin Endocrinol Metab; 2001 Mar; 86(3):957-64. PubMed ID: 11238469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anabolic therapies in osteoporosis.
    Rubin MR; Bilezikian JP
    Curr Opin Rheumatol; 2002 Jul; 14(4):433-40. PubMed ID: 12118181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic skeletal therapy for osteoporosis.
    Girotra M; Rubin MR; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Past and future of anabolic agents.
    Ringe JD
    Ann Med Interne (Paris); 2000 Oct; 151(6):482-9. PubMed ID: 11104928
    [No Abstract]   [Full Text] [Related]  

  • 6. Anabolic agents for treating postmenopausal osteoporosis.
    Meunier PJ
    Joint Bone Spine; 2001 Dec; 68(6):576-81. PubMed ID: 11809001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular and clinical parameters of anabolic therapy for osteoporosis.
    Rosen CJ
    Crit Rev Eukaryot Gene Expr; 2003; 13(1):25-38. PubMed ID: 12839095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALX 111: ALX1-11, parathyroid hormone (1-84) - NPS Allelix, PREOS, PTH, recombinant human parathyroid hormone, rhPTH (1-84).
    Adis International Ltd
    Drugs R D; 2003; 4(4):231-5. PubMed ID: 12848587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
    Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
    Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miscellaneous and experimental agents.
    Reginster JY
    Am J Med Sci; 1997 Jan; 313(1):33-40. PubMed ID: 9001164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
    Black DM; Greenspan SL; Ensrud KE; Palermo L; McGowan JA; Lang TF; Garnero P; Bouxsein ML; Bilezikian JP; Rosen CJ;
    N Engl J Med; 2003 Sep; 349(13):1207-15. PubMed ID: 14500804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone and its analogues--molecular mechanisms of action and efficacy in osteoporosis therapy.
    Misiorowski W
    Endokrynol Pol; 2011; 62(1):73-8. PubMed ID: 21365583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Male osteoporosis: current treatments and future options].
    Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S
    Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anabolic therapies in osteoporosis.
    Rubin MR; Bilezikian JP
    Endocrinol Metab Clin North Am; 2003 Mar; 32(1):285-307. PubMed ID: 12699304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstructing the skeleton with intermittent parathyroid hormone.
    Seeman E; Delmas PD
    Trends Endocrinol Metab; 2001 Sep; 12(7):281-3. PubMed ID: 11504661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTH-analogs: comparable or different?
    Verhaar HJJ; Lems WF
    Arch Gerontol Geriatr; 2009; 49(2):e130-e132. PubMed ID: 19124166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.